106 related articles for article (PubMed ID: 18296861)
1. The influence of mast cell mediators on migration of SW756 cervical carcinoma cells.
Rudolph MI; Boza Y; Yefi R; Luza S; Andrews E; Penissi A; Garrido P; Rojas IG
J Pharmacol Sci; 2008 Feb; 106(2):208-18. PubMed ID: 18296861
[TBL] [Abstract][Full Text] [Related]
2. TNFalpha increases in vitro migration of human HPV18-positive SW756 cervical carcinoma cells.
Hidalgo K; Rojas IG; Penissi AB; Rudolph MI
Biocell; 2005 Dec; 29(3):303-11. PubMed ID: 16524252
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.
Samson MT; Small-Howard A; Shimoda LM; Koblan-Huberson M; Stokes AJ; Turner H
J Immunol; 2003 May; 170(10):4953-62. PubMed ID: 12734338
[TBL] [Abstract][Full Text] [Related]
5. The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.
Jonsson KO; Persson E; Fowler CJ
Life Sci; 2006 Jan; 78(6):598-606. PubMed ID: 16111718
[TBL] [Abstract][Full Text] [Related]
6. Silencing of H4R inhibits the production of IL-1β through SAPK/JNK signaling in human mast cells.
Ebenezer AJ; Prasad K; Rajan S; Thangam EB
J Recept Signal Transduct Res; 2018 Jun; 38(3):204-212. PubMed ID: 29863427
[TBL] [Abstract][Full Text] [Related]
7. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract.
Sander LE; Lorentz A; Sellge G; Coëffier M; Neipp M; Veres T; Frieling T; Meier PN; Manns MP; Bischoff SC
Gut; 2006 Apr; 55(4):498-504. PubMed ID: 16299042
[TBL] [Abstract][Full Text] [Related]
8. Histamine modulates mast cell degranulation through an indirect mechanism in a model IgE-mediated reaction.
Carlos D; Sá-Nunes A; de Paula L; Matias-Peres C; Jamur MC; Oliver C; Serra MF; Martins MA; Faccioli LH
Eur J Immunol; 2006 Jun; 36(6):1494-503. PubMed ID: 16703563
[TBL] [Abstract][Full Text] [Related]
9. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
Xu X; Liu Y; Huang S; Liu G; Xie C; Zhou J; Fan W; Li Q; Wang Q; Zhong D; Miao X
Cancer Genet Cytogenet; 2006 Nov; 171(1):31-8. PubMed ID: 17074588
[TBL] [Abstract][Full Text] [Related]
11. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
Börner C; Höllt V; Sebald W; Kraus J
J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.
Small-Howard AL; Shimoda LM; Adra CN; Turner H
Biochem J; 2005 Jun; 388(Pt 2):465-73. PubMed ID: 15669919
[TBL] [Abstract][Full Text] [Related]
14. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of histamine H4 receptor on human mast cells.
Jemima EA; Prema A; Thangam EB
Mol Immunol; 2014 Nov; 62(1):19-28. PubMed ID: 24934979
[TBL] [Abstract][Full Text] [Related]
16. The Interplay between the Immune and the Endocannabinoid Systems in Cancer.
Braile M; Marcella S; Marone G; Galdiero MR; Varricchi G; Loffredo S
Cells; 2021 May; 10(6):. PubMed ID: 34064197
[TBL] [Abstract][Full Text] [Related]
17. Anandamide inhibits FcεRI-dependent degranulation and cytokine synthesis in mast cells through CB
Cruz SL; Sánchez-Miranda E; Castillo-Arellano JI; Cervantes-Villagrana RD; Ibarra-Sánchez A; González-Espinosa C
Int Immunopharmacol; 2018 Nov; 64():298-307. PubMed ID: 30243065
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids.
Vannacci A; Giannini L; Passani MB; Di Felice A; Pierpaoli S; Zagli G; Fantappiè O; Mazzanti R; Masini E; Mannaioni PF
J Pharmacol Exp Ther; 2004 Oct; 311(1):256-64. PubMed ID: 15187170
[TBL] [Abstract][Full Text] [Related]
19. Histamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity.
Deiteren A; De Man JG; Ruyssers NE; Moreels TG; Pelckmans PA; De Winter BY
Gut; 2014 Dec; 63(12):1873-82. PubMed ID: 24561612
[TBL] [Abstract][Full Text] [Related]
20. Effects of Viola yedoensis Makino anti-itching compound on degranulation and cytokine generation in RBL-2H3 mast cells.
Zeng HR; Wang B; Zhao Z; Zhang Q; Liang MY; Yao YQ; Bian K; Zhang WR
J Ethnopharmacol; 2016 Aug; 189():132-8. PubMed ID: 27196296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
